Welcome to our dedicated page for Ascend Wellness SEC filings (Ticker: AAWH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ascend Wellness Holdings filings document the regulatory record of a multi-state, vertically integrated cannabis operator with Class A common stock quoted on OTCQX and listed on the CSE. Its 8-K reports furnish operating results, preliminary financial results, liquidity and debt disclosures, retail-footprint updates, and material-event records tied to its cannabis retail, wholesale, and consumer packaged goods business.
Proxy and governance filings cover director elections, auditor ratification, stock incentive plan matters, and annual meeting voting. Other filings document capital-structure changes, including the automatic conversion of Class B common stock into Class A common stock and the related retirement of Class B shares, as well as arbitration-related disclosures and settlement of a previously reported award.
Ascend Wellness Holdings, Inc. has filed a shelf registration covering up to $100,000,000 of securities it may offer and sell from time to time. The company can issue Class A common stock, preferred stock, warrants, debt securities, subscription rights, or units in one or more future offerings, with final terms for each sale to be detailed in a separate prospectus supplement.
Ascend is a vertically integrated multi-state cannabis operator focused on limited-license adult-use markets. As of December 18, 2025, it operates 46 dispensaries, including 8 partner locations, across Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania, and runs cultivation facilities in six states with about 258,000 square feet of canopy. Its Class A common stock trades on the CSE under “AAWH.U” and on the OTCQX under “AAWH.”
Ascend Wellness Holdings (AAWH) reported softer results for the quarter ended September 30, 2025. Revenue was $124.7 million, down from $141.6 million a year ago, as both retail and third‑party wholesale sales declined. Gross profit held roughly steady, but operating expenses kept the business near break‑even at the operating line, and interest expense weighed on results. The company posted a net loss of $25.8 million, versus a $28.3 million loss last year.
For the first nine months of 2025, revenue totaled $380.0 million with a net loss of $69.5 million. AAWH ended the quarter with cash of $87.3 million, long‑term debt of $343.7 million, and stockholders’ equity of $2.6 million. Management disclosed indicators raising substantial doubt about going concern, but said this was alleviated by cash on hand and $21.7 million of net cash provided by operating activities year‑to‑date. The company completed several tuck‑in transactions for dispensaries and licenses during 2025. As of November 6, 2025, Class A shares outstanding were 202,269,004, with 65,000 Class B shares.
Ascend Wellness Holdings (AAWH) furnished quarterly results. The company reported that it issued a press release announcing financial results for the quarter ended September 30, 2025, and furnished it as Exhibit 99.1 to an 8-K.
The information was provided under Item 2.02 and is designated as “furnished,” not “filed,” which limits its use under the Exchange Act. The press release is dated November 10, 2025, and the 8-K was signed by Chief Financial Officer Roman Nemchenko.